Thank you, Mr. Chair.
Thank you to the ambassador and the witnesses for their time.
My first question is about COVAX and the fair allocation framework. The criterion is equality of coverage. That's a primary criterion. Could the witnesses please speak about how COVAX doses are directed to specific countries? Who manages the delivery and the handover to the countries, and who is responsible for the domestic rollout? We've had conversations about how COVAX gets the doses, but what happens once they have them?